Literature DB >> 17882791

By blocking apoptosis, Bcl-2 in p38-dependent manner promotes cell cycle arrest and accelerated senescence after DNA damage and serum withdrawal.

Anna Nelyudova1, Nikolay Aksenov, Valery Pospelov, Tatiana Pospelova.   

Abstract

E1A+ras-transformed rodent fibroblasts are unable to be arrested in the cell cycle and die by apoptosis in response to cytostatics, ionizing radiation (IR), or serum withdrawal. Overexpression of the human antiapoptotic gene bcl-2 suppresses apoptosis and induces reversible cell cycle arrest after IR or serum withdrawal and cell senescence after adriamycin treatment. Bcl-2-sustained adriamycin-induced cell senescence requires p38 MAPK, since the knockout of p38 MAPK abrogated anti-apoptotic and senescence-inducing effects of Bcl-2 in adriamycin-treated cells. Moreover, resistance to apoptosis and cell cycle arrest were not observed in p38-/- E1A+ras+bcl-2-transformants following IR or serum deprivation. However, the pro-apoptotic effect of nocodazole in E1A+ras-transformed cells can not be prevented by Bcl-2 overexpression independently of the presence of p38 MAPK. These results allow us to conclude that p38 is necessary for Bcl-2-induced inhibition of apoptosis, induction of cell cycle arrest and accelerated senescence after DNA damage and serum starvation, but not after nocodazole treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17882791     DOI: 10.4161/cc.6.17.4610

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  14 in total

1.  Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapy.

Authors:  Yue Zhang; Lukas W Pfannenstiel; Elzbieta Bolesta; Carolina L Montes; Xiaoyu Zhang; Andrei I Chapoval; Ronald B Gartenhaus; Scott E Strome; Brian R Gastman
Journal:  Clin Cancer Res       Date:  2011-06-28       Impact factor: 12.531

Review 2.  Senescence and apoptosis: dueling or complementary cell fates?

Authors:  Bennett G Childs; Darren J Baker; James L Kirkland; Judith Campisi; Jan M van Deursen
Journal:  EMBO Rep       Date:  2014-10-13       Impact factor: 8.807

3.  BN52021 protects rat cardiomyocyte from doxorubicin induced cardiotoxicity.

Authors:  Wen Yan; Chengluan Xuan; Lei Xuan; Rihao Xu; Junnan Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.

Authors:  Valentina Grossi; Alessia Peserico; Tugsan Tezil; Cristiano Simone
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis.

Authors:  Nanchang Xie; Hui Li; Dailin Wei; Gene LeSage; Lin Chen; Shengjun Wang; Yi Zhang; Lingyi Chi; Kenneth Ferslew; Lei He; Zhaofu Chi; Deling Yin
Journal:  Neuropharmacology       Date:  2010-06-22       Impact factor: 5.250

6.  Beneficial Effects of AMP-Activated Protein Kinase Agonists in Kidney Ischemia-Reperfusion: Autophagy and Cellular Stress Markers.

Authors:  Anne-Emilie Declèves; Kumar Sharma; Joseph Satriano
Journal:  Nephron Exp Nephrol       Date:  2014-12-06

Review 7.  The Intricate Interplay between Mechanisms Underlying Aging and Cancer.

Authors:  Amanda Piano; Vladimir I Titorenko
Journal:  Aging Dis       Date:  2014-02-16       Impact factor: 6.745

8.  Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells.

Authors:  Kuan-Chun Huang; Junzheng Yang; Michelle C Ng; Shu-Kay Ng; William R Welch; Michael G Muto; Ross S Berkowitz; Shu-Wing Ng
Journal:  Eur J Cancer       Date:  2016-09-24       Impact factor: 9.162

9.  p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells.

Authors:  Paolo Spallarossa; Paola Altieri; Chiara Barisione; Mario Passalacqua; Concetta Aloi; Giuseppina Fugazza; Francesco Frassoni; Marina Podestà; Marco Canepa; Giorgio Ghigliotti; Claudio Brunelli
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

10.  Proteinopathy-induced neuronal senescence: a hypothesis for brain failure in Alzheimer's and other neurodegenerative diseases.

Authors:  Todd E Golde; Victor M Miller
Journal:  Alzheimers Res Ther       Date:  2009-10-12       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.